| IPO Company Profile © ipodata.com |
| Message Board | Quote | Chart | News | SEC Filings | Peer IPO Companies |
| Vascular Solutions, Inc. |
| 2495 Xenium Lane North, Minneapolis, MN 55441 * (612) 553-2970 |
| Business Description | The company manufactures, markets and sells the Vascular Solutions Duett sealing device, which enables cardiologists and radiologists to rapidly seal the puncture site following catheterization procedures such as angiography, angioplasty and stenting. |
| Offering Information Company has | |||
| Trading As | VASC (NASNTL) | Industry | Manufacturing (SIC 3841) |
| Type of Stock Offered | Common Shares | Filing Date | 7/30/99 |
| Domestic Shares Offered | 3,500,000 | Offer Date | 7/19/00 |
| Foreign Shares Offered | 0 | Filing Range | $11.00 - $13.00 |
| Company Shares | 3,500,000 | Offer Price | $12.00 |
| Selling Shrhldrs Shares | 0 | Gross Spread | $0.840 |
| Gross Proceeds | $42,000,000 | Selling | $0.500 |
| Expenses | - - | Reallowance | $0.100 |
| Post-IPO Shares | 11,720,000 | Employees | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| Salomon Smith Barney | Lead Manager | (212) 723-7300 |
| Stephens Inc. | Co-manager | (501) 377-2130 |
| William Blair & Company | Co-manager | (312) 364-8990 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 6 Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/98 | 12/31/99 | 6/30/98 | 6/30/99 | |||
| Revenues | - | - | - | 0.000 | 0.494 | 0.133 | 0.514 |
| Income from Oper. | - | - | - | 1.724 | -5.415 | -2.206 | -3.716 |
| Net Income | - | - | - | -1.652 | -5.141 | -2.045 | -3.533 |
| E.P.S | - | - | - | - | -0.890 | - | -0.470 |
| Revenue Growth (%) | - | - | - | - | 286.47 | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | - | - | - | - | - |
| Net Profit Margin (%) | - | - | - | - | - | - | - |
| Cash Flow - Oper. | -5.21 | -2.18 | -3.58 | ||||
| Cash Flow - Inv. | -0.58 | -0.49 | -0.15 | ||||
| Cash Flow - Fin. | 8.39 | 0.40 | 3.03 | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 6/30/99 | Financial Ratios | ||||
| Total Assets | 10.67 | Current Assets | 10.02 | Current Ratio | 29.14 |
| Total Liab. | 0.34 | Current Liab. | 0.34 | Debt Ratio | 3.22% |
| Total Equity | 10.33 | Working Cap. | 9.68 | Debt to Equity Ratio | 0.03 |
| Cash | 9.20 | Return on Assets | - | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used to hire, train and deploy a direct United States sales force, and for working capital and general corporate purposes. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Dorsey & Whitney |
| Bank's Law Firm | Katten Muchin & Zavis |
| Registrar/Transfer Agent | Norwest Bank of Minnesota |
| Auditor | Ernst & Young |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |